- Home
- REVB vs SGD Comparison
REVB vs SGD Comparison
Compare REVB & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- SGD
- Stock Information
- Founded
- REVB 2020
- SGD 2021
- Country
- REVB United States
- SGD United States
- Employees
- REVB N/A
- SGD N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- SGD
- Sector
- REVB Health Care
- SGD
- Exchange
- REVB Nasdaq
- SGD Nasdaq
- Market Cap
- REVB 4.4M
- SGD 4.4M
- IPO Year
- REVB N/A
- SGD N/A
- Fundamental
- Price
- REVB $1.55
- SGD $1.34
- Analyst Decision
- REVB
- SGD
- Analyst Count
- REVB 0
- SGD 0
- Target Price
- REVB N/A
- SGD N/A
- AVG Volume (30 Days)
- REVB 890.8K
- SGD 342.8K
- Earning Date
- REVB 11-07-2025
- SGD 08-15-2025
- Dividend Yield
- REVB N/A
- SGD N/A
- EPS Growth
- REVB N/A
- SGD N/A
- EPS
- REVB N/A
- SGD N/A
- Revenue
- REVB N/A
- SGD $1,536,255.00
- Revenue This Year
- REVB N/A
- SGD N/A
- Revenue Next Year
- REVB N/A
- SGD N/A
- P/E Ratio
- REVB N/A
- SGD N/A
- Revenue Growth
- REVB N/A
- SGD 1570.24
- 52 Week Low
- REVB $1.50
- SGD $0.65
- 52 Week High
- REVB $60.48
- SGD $6.25
- Technical
- Relative Strength Index (RSI)
- REVB 25.99
- SGD 55.06
- Support Level
- REVB $1.50
- SGD $1.02
- Resistance Level
- REVB $2.90
- SGD $1.39
- Average True Range (ATR)
- REVB 0.20
- SGD 0.15
- MACD
- REVB -0.13
- SGD 0.02
- Stochastic Oscillator
- REVB 3.57
- SGD 51.58
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About SGD Safe and Green Development Corporation
Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.